Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2-breast cancer and residual disease after neoadjuvant chemotherapy: brief trial updates - Loibl, Sibylle; Martin, M.; Bonnefoi, H.; Untch, M.; Kim, S. -B.; Bear, H. D.; García-Sáenz, J. A.; Melé Olivé, M.; Mc Carthy, N.; Gelmon, K.; Kelly, C. M.; Im, S. -A.; et al. (Annals of oncology, 2025)
Online verfügbar: 24. März 2025, Artikelversion: 13. Juni 2025